Food With The Guts To Stand Up To CancerJuly 22, 2004Cancers of the gut are one of the major causes of death from cancer, but a review published this week[1] shows that they are also amongst the most preventable through changes in diet. Of the 10 million new cases of cancer diagnosed in 2000, around 2.3 million were cancers of the digestive organs - pharynx, oesophagus, stomach or colorectum. Studies have shown that they are not purely genetic and can be modified by diet. Professor Ian Johnson, author of the review and head of Gastrointestinal Health and Function at the Institute of Food Research, said: "The adverse effects of diet are caused by over-consumption of energy coupled with inadequate intakes of protective substances, such as micronutrients, dietary fibre and a variety of plant chemicals". The walls of the gut are lined with a layer of cells, the epithelium, covered with a film of mucus. The epithelium is the first contact for food, bacteria and anything else ingested. It is the body's first line of internal defence, but can also be susceptible to the development of abnormalities over time. The epithelium is normally renewed by rapidly dividing stem cells, which can also give rise to new growths called polyps. These usually remain benign, but some may acquire so many genetic abnormalities that they eventually form a cancerous tumour. There is evidence that some food components including fibre, folate, polyunsaturated fatty acids, plant chemicals such as glucosinolates or flavonoids and gut fermentation products such as butyrate can provide protection at various stages of cancer formation. For example, in research published in the same journal, enzymes called COX-2 that enable genetically abnormal cells to survive were suppressed by the flavonoid quercetin[2]. Compounds can also increase the activity of detoxifying enzymes, and components in the diet have been shown to act synergistically in this way - so that they are even more effective when combined[3]. These enzymes delete genetically damaged epithelial cells. "Cancers of the colon and rectum are the most common cancers of the digestive organs worldwide", said Professor Johnson. "But rates are much higher in developed countries. Colorectal cancer is clearly a disease of affluence and about 80 per cent of cases are attributable in some way to diet. Many of the mechanisms have yet to be discovered, but basically what this means is that people can help to protect themselves by controlling their weight and by eating diets rich in fruits and vegetables and other sources of fibre". "Cancer is a complex multistage process that can take a large proportion of a person's lifespan to develop. Nutrition is potentially a powerful tool to interrupt many stages of that process, and could be much more effectively deployed by many people", he said. | |||||||||||||||||||||
|
Related Cancer News Articles Bisphenol A linked to metabolic syndrome in human tissue New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics-bisphenol A (BPA)-as a risk factor for metabolic syndrome and its consequences. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD). Atomic structure of the mammalian 'fatty acid factory' determined Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. International team reveals first prognosticator of survival in aggressive cancer The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS). M. D. Anderson study finds change in HER2 status after treatment with Herceptin Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery. M. D. Anderson study finds racial disparities in radiation therapy rates for breast cancer Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. NC State Is First University in Nation to Offer Canine Bone Marrow Transplants Dogs suffering from lymphoma will be able to receive the same type of medical treatment as their human counterparts, as North Carolina State University becomes the first university in the nation to offer canine bone marrow transplants in a clinical setting. DNA editing tool flips its target Imagine having to copy an entire book by hand without missing a comma. Our cells face a similar task every time they divide. They must duplicate both their DNA and a subtle pattern of punctuation-like modifications on the DNA known as methylation. What a Sleep Study Can Reveal About Fibromyalgia Research engineers and sleep medicine specialists from two Michigan universities have joined technical and clinical hands to put innovative quantitative analysis, signal-processing technology and computer algorithms to work in the sleep lab. Stem cell research puts interstate rivalry on hold Victoria and New South Wales have put aside their competitive interstate rivalry to collaborate on a stem cell research project, as announced by Innovation Minister Gavin Jennings and NSW Minister for Science and Medical Research, Verity Firth, today. More Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||